Affitech A/S Release: Due Date Extended for Short Term Loan Provided by Trans Nova
10/12/2012 9:34:05 AM
More...
|
The Delisting of Affitech A/S is Suspended by NASDAQ OMX Copenhagen A/S
10/11/2012 9:31:25 AM
More...
|
GE Healthcare Life Sciences Executes Recombinant Protein License from Affitech A/S
10/17/2011 10:29:04 AM
More...
|
Selexis SA CEO Elected to Board of Affitech A/S
7/13/2011 6:31:48 AM
More...
|
Avid Bioservices, Inc. Secures Biomanufacturing Contract With Affitech AS
9/30/2010 9:03:46 AM
More...
|
Peregrine Pharmaceuticals, Inc. (PPHM) and Affitech AS to Amend License Agreements to Expedite Development of Novel Fully Human Anti-VEGF Antibody AT001/R84
9/30/2010 9:01:07 AM
More...
|
Affitech AS Appoints Dr. Robert Burns as CEO
9/1/2009 6:53:35 AM
More...
|
Peregrine Pharmaceuticals, Inc. (PPHM) Licenses Anti-VEGF Antibodies to Affitech AS
7/22/2009 7:51:25 AM
More...
|
Affitech AS-Discovered Anti-PS Antibodies in Development by Peregrine Pharmaceuticals, Inc. (PPHM) Show Excellent Functionality in Preclinical Studies
4/28/2009 8:56:31 AM
More...
|
Affitech AS Strengthens Patent Position on its Phagemid Antibody Screening Technology in Europe
4/2/2009 8:56:47 AM
More...
|
|